Table 2.
Baseline anthropometric and laboratory characteristics of participants by metabolic syndrome condition using National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP III) criteria.
| Having MetS | Without MetS | Total | p-Value | ||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | ||
| MetS by NCEP ATP III (n, %) | 1056 | 22.5 | 3645 | 77.5 | |||
| MetS by IDF (n, %) | 468 | 10.0 | 4233 | 90.0 | |||
| Weight (kg) | 57.5 | 10.4 | 51.3 | 8.5 | 52.7 | 9.3 | <0.01 * |
| Height (cm) | 156.0 | 8.1 | 157.0 | 7.7 | 156.8 | 7.8 | <0.01 * |
| Waist circumference (WC, cm) | 81.4 | 9.8 | 71.8 | 7.8 | 73.9 | 9.2 | <0.01 * |
| Hip circumference (cm) | 92.2 | 7.0 | 87.2 | 5.9 | 88.3 | 6.5 | <0.01 * |
| Body mass index (kg/m2) | 23.6 | 3.4 | 20.8 | 2.6 | 21.4 | 3.1 | <0.01 * |
| Waist–hip ratio (WHR) | 0.9 | 0.1 | 0.8 | 0.1 | 0.8 | 0.1 | <0.01 * |
| Waist–height ratio (WHtR) | 0.5 | 0.1 | 0.5 | 0.1 | 0.5 | 0.1 | 0.50 * |
| Body fat percentage (%) | 29.8 | 6.5 | 23.6 | 6.5 | 25.0 | 7.0 | <0.01 * |
| Systolic blood pressure (mmhg) | 142.3 | 21.7 | 121.6 | 20.2 | 126.3 | 22.3 | <0.01 * |
| Diastolic blood pressure (mmhg) | 86.4 | 12.4 | 75.5 | 12.1 | 78.0 | 13.0 | <0.01 * |
| Total cholesterol (mg/dL) | 5.4 | 1.2 | 4.7 | 1.0 | 4.9 | 1.1 | <0.01 * |
| HDL cholesterol (mg/dL) | 1.0 | 0.2 | 1.3 | 0.3 | 1.2 | 0.3 | <0.01 * |
| LDL cholesterol (mg/dL) | 3.3 | 1.1 | 2.7 | 0.9 | 2.9 | 0.9 | <0.01 * |
| Triglycerides (mg/dL) | 2.7 | 1.6 | 1.4 | 0.9 | 1.7 | 1.2 | <0.01 * |
| Fasting blood glucose (mg/dL) | 6.0 | 2.0 | 4.9 | 0.9 | 5.2 | 1.3 | <0.01 * |
| Abdominal Volume Index (AVI) | 13.5 | 3.2 | 10.6 | 2.2 | 11.3 | 2.8 | <0.01 * |
| Body roundness index (BRI) | 3.9 | 1.2 | 2.6 | 0.8 | 2.9 | 1.1 | <0.01 * |
| A body shape index (ABSI) | 0.08 | 0.01 | 0.08 | 0.01 | 0.08 | 0.01 | 0.05 * |
| Body adiposity index (BAI) | 29.5 | 4.5 | 26.4 | 3.6 | 27.1 | 4.0 | <0.01 * |
| Conicity index (CI) | 1.2 | 0.1 | 1.2 | 0.1 | 1.2 | 0.1 | 0.05 * |
* Mann-Whitney U test.